Alto Labs LLC

SEC filing

Pharmaceuticals · Los Angeles, CA

Form D on EDGAR

Amount raised$300Ksold at filing

Total offering$400K$100K still open

Investors in the raise2count reported to the SEC

FiledOct 2, 2025first sale Aug 14, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Adam SolomonExecutive Officer

Matthew MakabehExecutive Officer

Oliver CohenExecutive Officer

Executive officers, directors and promoters as listed on the Form D.